TMCnet News
BeiGene to Present at the 8th SVB Leerink Global Healthcare ConferenceCAMBRIDGE, Mass. and BEIJING, China, Feb. 22, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced that the company will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY. The presentation is scheduled for 10:00 a.m. EST on Friday, March 1st, 2019. A live webcast can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com/. An archived replay will be available for 90 days following the event. About BeiGene Investor Contact Media Contact _____________________________ |